Boosted by its exclusive agreement with Regeneron, Kiniksa Pharmaceuticals stands among the top biotech stocks to watch.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

The list of departing ASX biotech CEOs continues to swell, with Medical Developments chief Brent MacGregor signing off today.

While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...

While industry leaders are unsure whether the U.S. or China will prevail, they are largely united in the belief that Europe ...

Portal Innovations today announced the release of Biotech’s Next Frontier: Emerging Hubs Built for Efficiency and Outsized Returns, a new analysis developed by its venture team examining a decade of ...

It’s been a busy morning for Paragon Labs. In addition to bringing over much of the leadership team from AbbVie-acquired ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...

Investors did have some news to latch onto as the company announced that its subsidiary, Pinnacle Food AgTech HK Limited, ...